Cargando…
Anti-SARS-CoV-2 immunoglobulin profile in patients with celiac disease living in a high incidence area
BACKGROUND AND AIM: How symptoms and antibodies related to SARS-CoV-2 infection develop in patients with celiac disease (CD) is unclear. We aimed to investigate the impact of SARS-CoV-2 infection in CD patients. METHODS: CD patients were interviewed about the development of COVID-19 symptoms, compli...
Autores principales: | Elli, Luca, Facciotti, Federica, Lombardo, Vincenza, Scricciolo, Alice, Sanders, David S., Vaira, Valentina, Barisani, Donatella, Vecchi, Maurizio, Costantino, Andrea, Scaramella, Lucia, dell'Osso, Bernardo, Doneda, Luisa, Roncoroni, Leda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429410/ https://www.ncbi.nlm.nih.gov/pubmed/34561158 http://dx.doi.org/10.1016/j.dld.2021.08.027 |
Ejemplares similares
-
Fr006 IMPACT OF A SARS-COV2 INFECTION IN PATIENTS WITH CELIAC DISEASE
por: Elli, Luca, et al.
Publicado: (2021) -
Refractory celiac disease and COVID-19 outbreak: Findings from a high incidence scenario in Northern Italy
por: Elli, Luca, et al.
Publicado: (2020) -
How to manage celiac disease and gluten-free diet during the COVID-19 era: proposals from a tertiary referral center in a high-incidence scenario
por: Elli, Luca, et al.
Publicado: (2020) -
Correction to: How to manage celiac disease and gluten-free diet during the COVID-19 era: proposals from a tertiary referral center in a high-incidence scenario
por: Elli, Luca, et al.
Publicado: (2022) -
Clinical Value of Tissue Transglutaminase Antibodies in Celiac Patients over a Long Term Follow-Up
por: Farina, Elisa, et al.
Publicado: (2021)